An overview of lipid constituents in lipid nanoparticle mRNA delivery systems
WIREs Nanomedicine and Nanobiotechnology · 2024
DOI: 10.1002/wnan.1978 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Shiqi Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Liangzhu Laboratory, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Lipids. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 149 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, National Natural Science Fund for Excellent Young Scientists Fund Program (overseas).
Abstract (Originalsprache)
mRNA therapeutics have shown great potential for a broad spectrum of disease treatment. However, the challenges of mRNA's inherent instability and difficulty in cellular entry have hindered its progress in the biomedical field. To address the cellular barriers and deliver mRNA to cells of interest, various delivery systems are designed. Among these, lipid nanoparticles (LNPs) stand out as the most extensively used mRNA delivery systems, particularly following the clinical approvals of corona virus disease 2019 (COVID‐19) mRNA vaccines. LNPs are comprised of ionizable cationic lipids, phospholipids, cholesterol, and polyethylene glycol derived lipids (PEG‐lipids). In this review, we primarily summarize the recent advancements of the LNP mRNA delivery technology, focusing on the structures of four lipid constituents and their biomedical applications. We delve into structure–activity relationships of the lipids, while also exploring the future prospects and challenges in developing more efficacious mRNA delivery systems. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Biology‐Inspired Nanomaterials > Lipid‐Based Structures Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Liangzhu Laboratory, Zhejiang University, Hangzhou, China.
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
- State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, China.
ORCID-Profile: Shuai Liu
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- National Natural Science Fund for Excellent Young Scientists Fund Program (overseas)
- Zhejiang University Startup Package
Zitieren
APA
Wu, S., Lin, L., Shi, L., & Liu, S. (2024). An overview of lipid constituents in lipid nanoparticle mRNA delivery systems. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1978
Vancouver
Wu S, Lin L, Shi L, Liu S. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.1978
BibTeX
@article{Wu2024,
author = {Wu, Shiqi and Lin, Lixin and Shi, Lu and Liu, Shuai},
title = {An overview of lipid constituents in lipid nanoparticle mRNA delivery systems},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
doi = {10.1002/wnan.1978}
}
EUVIMED